Salix Pharmaceuticals, Ltd. - Strategy, SWOT and Corporate Finance Report
SynopsisSalix Pharmaceuticals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Summary
- Detailed information on Salix Pharmaceuticals, Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Salix Pharmaceuticals, Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Salix Pharmaceuticals, Ltd. including a breakdown and examination of key business segments
- Intelligence on Salix Pharmaceuticals, Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Salix Pharmaceuticals, Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Salix Pharmaceuticals, Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Salix Pharmaceuticals, Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Salix Pharmaceuticals, Ltd.'s business structure, strategy and prospects.
Key Highlights
Salix Pharmaceuticals (Salix or 'the company') is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of prescription pharmaceutical products for the treatment of gastrointestinal diseases. The company's marketed drugs include Xifaxan, Osmoprep and Metozolv ODT. Salix primarily operates in the US, where it is headquartered in Raleigh, North Carolina. It employed about 1,000 people as of December 31, 2014.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.